Surgepays Stock Analysis

Surgepays Stock Analysis Notes

About 29.0% of the company outstanding shares are owned by corporate insiders. The book value of Surgepays was at this time reported as 1.96. The company had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021. SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people. To find out more about Surgepays contact Kevin Cox at 901 302 9587 or learn more at https://surgepays.com.

Surgepays Investment Alerts

Surgepays Upcoming and Recent Events

Surgepays Largest EPS Surprises

View All Earnings Estimates

Surgepays Stock Institutional Investors

Note, although Surgepays' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Surgepays Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 65.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgepays's market, we take the total number of its shares issued and multiply it by Surgepays's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Surgepays Profitablity

The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.

Management Efficiency

Surgepays has return on total asset (ROA) of 0.3106 % which means that it generated a profit of $0.3106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.2317 %, meaning that it created $1.2317 on every $100 dollars invested by stockholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Other Assets is estimated to increase to about 213.5 K, while Non Currrent Assets Other are forecasted to increase to (512.5 K).

Technical Drivers

As of the 24th of April, Surgepays has the Variance of 43.05, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,193). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Surgepays, which can be compared to its competition. Please validate Surgepays risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 3.52 per share. Given that Surgepays has information ratio of (0.1), we advise you to double-check Surgepays's current market performance to make sure the company can sustain itself at a future point.

Surgepays Price Movement Analysis

Surgepays Insider Trading Activities

Surgepays Predictive Daily Indicators

Surgepays Corporate Filings

Surgepays Forecast Models

Surgepays' time-series forecasting models are one of many Surgepays' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgepays prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgepays shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgepays. By using and applying Surgepays Stock analysis, traders can create a robust methodology for identifying Surgepays entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgepays analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Surgepays stock analysis indicators help investors evaluate how Surgepays stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgepays shares will generate the highest return on investment. By understating and applying Surgepays stock analysis, traders can identify Surgepays position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.

Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.